Introduction
[Another page, another headline.] "Car plant expansion. 1·5 million rand plan." Ja. I'll tell you what that means . . . more machines, bigger buildings . . . never any expansion to the pay-packet. Makes me fedup. I know what I'm talking about. I worked at Ford one time. We used to read in the newspaper . . . big headlines! . . . "So and so from America or London made a big speech: ' . . . going to see to it that the conditions of their non-white workers in Southern Africa were substantially improved.'" The talk ended in the bloody newspaper. Never in the pay-packet. 1 Words first spoken on a Cape Town stage in 1972 capture the negative sentiment expressed regarding the actions and, many times, inactions of multinational corporations (MNCs). From business decisions that range from unfair wage and labor practices to environmental carelessness and pollution, MNCs have been, and continue to be, the target of much criticism. More recently, the response of such corporations to the global AIDS crisis has been challenged by corporate watchdogs, consumer groups, nongovernmental organizations (NGOs), and global leadership alike. The attacks on the seeming inattention of MNCs to the emerging global AIDS epidemic are often voiced in the language of corporate social responsibility.
2 Critics also present the right to life 3 -the right to accessible and affordable medical treatment-as a global human rights concern, and in this regard, many fervently argue that MNCs owe an ethical duty to their own employees.
vate and informal work sectors, and take measures to provide a supportive workplace environment for people living with HIV/AIDS." 8 By creating internal operations that extend "sideways transnationally across national borders," 9 MNCs can be affected in tremendous ways by harmful global conditions, such as the growing AIDS epidemic. Rather than advocating action by MNCs on the basis of corporate social responsibility, presenting the AIDS epidemic as a global workforce crisis provides critics with a meaningful framework through which to urge decisive and immediate effort. The increasing global infection rate among individuals of working age, in addition to the decline in health and well being of the countless people already infected, dramatically impacts both the global workforce on a grand scale and the workforces of discrete MNCs around the world.
By discussing the existing global AIDS epidemic, both in terms of the current framework of a human rights crisis, as well as in terms of the proposed framework of a global workforce crisis, this Note seeks to provide a common language by which MNCs and their critics may engage in productive dialogue. Part I of this Note briefly examines the current framework-AIDS as a global human rights crisis and the response of MNCs through corporate social responsibility. A case study of Cummins Inc. serves to highlight the response, including successes and shortcomings of one corporation's response to the AIDS crisis through the lens of corporate social responsibility. This part concludes with criticisms under the current framework.
Part II proposes an alternative framework through which MNCs, and their critics, may view issues and define responses. A global workforce crisis has emerged as a result of the AIDS epidemic. The disease often affects individuals in their prime working years across populations worldwide. Furthermore, AIDS directly affects the business operations of MNCs through increased costs, decreased productivity, and reduced profits. This part seeks to show that intervention by MNCs is cost-effective, in part by illustrating effective program implementations and their successes. Finally, this part concludes by demonstrating 720 Elizabeth M. Chitty that reframing the issue in terms of a global workforce crisis may dispel criticisms present under the current corporate social responsibility framework.
I. Current Framework: AIDS as a Global Human Rights Crisis
Concern has arisen regarding emerging human rights gaps between the rich and the poor, the powerful and the powerless. Although "the international human rights community" promotes the fundamental idea of basic human rights for all, some worry that the focus still remains too narrow:
[I]f this human rights community does not broaden its analysis and advocacy work to employ an "all rights guaranteed-all actors accountable" framework, it may contribute to the perpetuation of poverty and other injustices on a global scale. The impunity with which many "inter-state," "non-state" and "other state" actors violate the rights of individuals and peoples worldwide may continue unabated. 10 Acting under the human rights movement umbrella, global leaders, NGOs, and consumer groups seek to hold MNCs accountable for recognizing and addressing the basic human rights of their employees and extended communities in which such corporations operate. In the context of the MNC as employer, the human rights movement utilizes the language of corporate social responsibility.
A. The Right to Life as a Basic Human Right and the Response of MNCs through the Language of "Corporate Responsibility"
Human rights law is viewed as a powerful means through which to emphasize and redress the global HIV/AIDS crisis.
11 Corporate responsibility strives to encompass aspects of the human rights movement. 12 The corporate social responsibility movement addresses a variety of issues in current business practice- self-initiated general corporate codes of conduct. On the international level, "soft law" regarding corporate social responsibility has also emerged. 21 Critics, however, argue that the international codes lack sufficient substance to adequately address the growing demands of the AIDS crisis. Health GAP disclaims the benefit of such soft, nonlegally binding law that attempts to set guidelines for the role of MNCs in the AIDS crisis. Health GAP's criticisms are that:
[B]y refusing to present corporations a coherent mandate for workplace treatment programs, these initiatives do more harm than good. The GHI [Global Health Initiative], for example, in adopting the ILO [International Labour Organization] HIV/ AIDS code as "business best practice" for HIV/AIDS, sets an eminently low standard for businesses to meet in the area of providing workplace treatment. This "best practice" offers no added benefit to a worker faced with sickness and death from untreated HIV disease, but provides MNCs with all the benefits that accompany compliance with international standards, no matter how weak.
22
Despite the numerous criticisms aimed at the lack of substance and enforcement mechanisms of the current corporate responsibility movement, many MNCs have employed corporate social responsibility as a framework for their responses to the emerging global AIDS crisis. The following case study highlights the actions of one such corporation. individuals. 24 A key feature of this MNC is its decentralized corporate structure, consisting of four distinct business units and regional headquarters located around the world.
One aspect of Cummins's mission is to act in the best interests of all stakeholders; importantly, the corporation defines stakeholders broadly to include, among others, both employees and the communities in which the corporation operates. 25 Additionally, Cummins upholds six core values: integrity, innovation, delivering superior results, corporate responsibility, diversity, and global involvement. 26 Cummins's corporate social responsibility initiatives take place in part through the activities of The Cummins Foundation, whose mission is to "make people's lives better by: [s]erving and improving the communities in which Cummins Inc. does business, and [p]roviding the tools and means for people living on the edge of society to overcome the barriers they face." Cummins's commitment to the best interests of its stakeholders as well as to corporate responsibility has led to the company's involvement in the global fight against HIV/AIDS. Cummins's overarching philosophy, in combination with its decentralized corporate structure, allows specific policy and program implementation to occur on a local level. Rather than mandate company-wide policies, Cummins's strategy in addressing any prevailing issue truly embodies the motto "think globally, act locally."
The HIV/AIDS crisis illustrates both the necessity and increased effectiveness of acting at the local level and serves as a reminder that one approach rarely fits the needs of all. Although Cummins does not track statistics regarding HIV/ AIDS infection among its employees, it is clear that a fairly significant mass of its South African employees, where the rate of infection has drastically increased, are affected by this virus. Here, Cummins has partnered with the Careways Group, 28 an independent for-profit organization, in assisting with employee training and administration needs. American region (which includes Brazil), Cummins has begun employee training with a focus on HIV/AIDS education.
In India, the Cummins Foundation is currently working to develop a prevention and education program targeting local truck stop routes. 29 The Cummins Foundation is also in the process of exploring possibilities of partnering with Project Concern International 30 and the Bill and Melinda Gates Foundation 31 in fighting this deadly disease in India.
Cummins recognizes that AIDS is a moral, social, and health concern. Its decisions regarding similarly sensitive issues confirm the need to create and implement guidelines and procedures at a local level. Cultural norms vary from one operating location to the next, and effectiveness requires that such differences be taken into consideration when determining the most appropriate response. Both approaching the HIV/AIDS crisis in a location-and culture-specific manner and recognizing the global dimension of the HIV/AIDS crisis have led Cummins to realize that one of the greatest hurdles in determining the most effective components of a solution is the lack of a good "roadmap." countries eager to attract foreign investment and maintain operations of MNCs may be hesitant to impose legal duties out of fear of dissuading the corporations from pursuing development in that country. 33 Critics further suggest that if MNCs feel too much pressure from the local government, NGOs, or workers to provide AIDS treatment, the corporations may threaten "capital flight." 34
C. Limitations to Viewing

The "Bottom Line" as Multinational Corporations' Only Concern
Actions taken by MNCs are often greeted with skepticism. AIDS advocates and corporate watchdog groups question the motivation of corporations, 35 who, these critics allege, are too concerned with the "bottom line" of profit making, to the exclusion of legitimate worker issues. 36 They claim that in addition to seeking powerless population groups to exploit for profit, MNCs often wield their influence to earn favorable results in "manipulated international trade pacts and agreements, in order to maximize profits." 
Insufficiency/Nonsustainability of the Current Response of MNCs
The current response of MNCs to the global AIDS crisis has been criticized in at least two ways. First, many AIDS advocates strongly believe that the re-33. See, e.g., Yaghmaian, supra note 13 (discussing "destructive wage competition"). But see ILOAIDS, Collection of National Instruments Related to HIV/AIDS and the World of Work, at http:/ /www.ilo.org/public/english/protection/trav/aids/laws/index.htm (last modified Jan. 19, 2005) ("This collection contains legislative texts (hard law) and soft law instruments (codes of practice, guidelines, policies) dealing, entirely or in part, with HIV/AIDS and the world of work.").
34. Yaghmaian, supra note 13 (discussing the threat of "capital flight" in the context of wage law 39 Where MNCs have implemented treatment programs, others feel that the programs do not reach as many workers as necessary or that they exact too great a financial burden from those benefiting. 40 Many of the "naming and shaming campaigns" focus not on the MNCs that have managed to entirely sidestep the issue, but rather on those that make public promises of actions that have failed to be fully implemented or fail to reach as broadly as critics would like. 41 Second, responses of MNCs through philanthropic donations or established corporate "foundations" are viewed as insufficient and nonsustainable. Critics argue that "[p]rivate charities, even if they are guided by good intentions, cannot make a dent into this problem," 42 and that long-lasting solutions involve more than philanthropic gestures. They believe that corporate donor programs 43 and pharmaceutical companies' reductions in antiretroviral drug prices are equally nonsustainable. 44 The framework of corporate social responsibility remains vulnerable as a result of its inherent shortcomings. Those who view and challenge the response 38. See, e.g., Baker, supra note 18 ("[S]ome MNCs are beginning to acknowledge the scope of the pandemic and plan minimal face-saving responses that protect limited segments of their skilled workforce.").
39. See id. 40. See, e.g., id. (criticizing the 2001 decision of Anglo-American subsidiary AngloGold "to offer ARV therapy to office and management staff only, mostly white, but not to frontline miners, mostly [b] lack" and the decision of DeBeers "to provide coverage to one dependant and to workers and that dependant for life, but … to impose a 10% co-pay which could cost workers hundreds of dollars a year").
41. See, e.g., id. (praising the success of campaigns against corporations such as AngloGold and DeBeers).
42. Yaghmaian, supra note 13 ("Africans will die in rising numbers while we debate the merits of free market capitalism, and wait for the kind-heartedness of pharmaceutical firms to lower their prices for distribution in Africa.").
43. Health GAP, supra note 15 ("Sustained access [to life-saving drugs] cannot result from industry-controlled charity programs.").
44. Rachel Cohen, Wealthy Countries Should Help Developing Countries Acquire AIDS Drugs, in AIDS: Opposing Viewpoints 52, 56-57 (Tamara L. Roleff ed., 2003) ("It is critical that a longterm, sustainable solution to the crisis of lack of access to medicines be developed-not one that relies solely on the good will of pharmaceutical companies to voluntarily offer discounts on certain medicines. Though such price reductions are important, they are extremely vulnerable strategies on their own.").
to the AIDS crisis solely in this limited fashion also fail to accurately capture the devastation that MNCs may experience. 45 This occurs in spite of the fact that "AIDS is no longer just a niche issue for companies wishing to demonstrate corporate leadership to a particular group important to their business. It is one of the defining global issues that will affect market development and the performance of individual companies over the next half century."
46 While MNCs may care about the global AIDS epidemic as a human rights crisis in terms of corporate social responsibility (and arguably should), they must care about the epidemic as a threat to the global workforce.
II. Proposed Framework: AIDS as a Global Workforce Crisis And the Emerging Role of MNCs
The proposed framework, as compared to the current framework of corporate social responsibility, builds on the premise that "business' main business is business." 47 In setting aside any philosophical or moral argument as to the motivation that should drive corporate response, this framework focuses on a pragmatic approach: MNCs must treat the AIDS crisis as an emerging business issue. 48 More poetically phrased, "HIV/AIDS is a matter of enlightened self-interest."
49 MNCs must take action against the growing AIDS epidemic, not simply as a matter of corporate responsibility, but to protect their interests in maintaining the global workforce.
MNCs have a vested interest in preserving human capital as one of many elements necessary to operate any business. The AIDS crisis affects populations around the world and particularly targets individuals of working age; 50 the epi- 
A. AIDS Affects Individuals Across Populations Worldwide in the Prime of Their Working Years
The HIV/AIDS crisis continues to worsen. Almost 5 million individuals became HIV-positive in 2003 alone-the highest rate of infection in a single year since the epidemic began. 53 The AIDS pandemic is undeniably global in nature, leaving no area of the world unaffected. The disease, however, strikes different regions and countries in dramatically varying degrees. 55. HIV/AIDS and Work, supra note 45, at 10 (charting the male and female life expectancy projections, both with and without the disease, in the 10 countries most affected by HIV/AIDS).
56. See id. at 4 (noting that the average regional frequency of HIV infection among working aged individuals is 7.7%).
can countries with a population-wide infection rate higher than 20 percent. 57 In Zimbabwe, Zambia, and Swaziland, the life expectancy is forecasted to fall below thirty-five years of age without the implementation of treatment programs.
58
In addition to severely reducing life expectancy rates, HIV/AIDS can dramatically alter existing population patterns: "[w]hen there is a major HIV/AIDS epidemic, large sections of infants could die due to Mother to Child Transmission. This combined with high mortality rate in the reproductive age group and unchanged mortality pattern among the elderly produces a 'chimney pattern. '" 59 Such long-term modifications to basic population structures carry grave implications for the present, as well as the future, state of affairs. The AIDS-induced collapse of family and community structure generally, including the premature death of caregivers and the increasing number of orphaned children, further decreases the viability of future workforces. 60. See HIV/AIDS and Work, supra note 45, at 6 (suggesting that "the long-term costs of ignoring the role of the family in preparing future generations for productive work, and in the creation of the human capacity for socio-economic development, [ agricultural and industrial sectors." 64 The International Labour Organization projects that by 2020, the workforce population in thirty-two African countries will have decreased in size by 5 percent to 35 percent as a result of the AIDS epidemic. 65 Without increases in essential AIDS treatment, the aggregate loss of members of the global workforce is predicted to total 28 million by 2005 . 66 This number, if current prevention and treatment practices remain unchanged, will increase to 48 million by 2010 and to 74 million by 2015. 67 Certain business sectors remain more susceptible to the threat of HIV/AIDS than others. For example, those sectors employing a workforce predominantly removed from family and community, such as the mining industry, experience a heightened risk of transmission among the workers. 68 Many times, workers in this industry, as well as industries which utilize mobile or migratory workforces, are housed in all-male housing close to the worksite, and sex workers often reside nearby. 69 Not only does the isolated environment suggest increased rates of infection, but HIV/AIDS infection spreads to the remote towns and villages upon the workers' return. 70 Workers engaged in the transportation sector, including the trucking industry, similarly are exposed to an above-average risk of infection.
71
With regard to such mobile workforces, HIV/AIDS infection spreads throughout the region when workers engage in high-risk behavior and then move about as their employment responsibilities dictate. 72. See, e.g., Baker, supra note 18 ("Multinational corporations have insisted on the development of transportation infrastructures, but have made no provision to prevent or reduce HIV transmission along truck routes, at sea ports, and along other systems of transportation.").
B. AIDS Directly Affects the Operations of MNCs
The AIDS epidemic not only affects the make-up and viability of the current and future population structure and the viability of the global workforce, but also directly and indirectly shapes the current business operations of MNCs on a day-to-day basis. 73 The epidemic has resulted in increased costs, decreased productivity, and reduced profits for many companies, the effects of which are often interconnected. 
AIDS Results in Increased Costs to the Corporation
Estimates suggest that by 2005, the physical repercussions of AIDS will force 2 million members out of the workforce entirely, and by 2015, more than 4 million workers will be unable to continue active employment. 75 Even now, African companies sometimes hire two employees per position because of the likelihood that AIDS will render one unable to work. 76 For MNCs providing health care benefits to their employees, the cost of insurance premiums and claims will inevitably rise. 77 Additional costs accrue as a result of the necessary recruiting and training of new employees to replace those workers debilitated and unable to continue working due to the physical effects of AIDS. Such an increase in employee turnover also leads generally to a less-trained and less-skilled workforce. The ever increasing price of health care, the reduction of experienced and skilled workers due to sickness and death, and AIDS-related absenteeism are among the leading 74. See Action Against AIDS, supra note 48 (chart illustrating "how these costs combine and reinforce each other to reduce the revenue and profits of enterprises."). While the chart indicates many possible negative effects of AIDS on the workplace, it is important to note that not every aspect of AIDS in the workplace may affect each MNC, or at least not to the same extent.
75 
AIDS Results in Decreased Productivity within the Corporation
In the words of Mervyn Davies, Group Chief Executive for Standard Chartered Bank, "AIDS imposes a day-to-day economic 'tax' that compromises business productivity."
80 Productivity is lowered as AIDS begins to affect the physical well being of an MNC's employees. A skilled worker may at first merely become slow at his job, but as the disease continues to take its toll, absence from the workplace frequently occurs. Eventually, the employee becomes incapacitated to the point that work is no longer a possibility and he must suspend or quit his employment. Productivity remains decreased until the position is filled once again, but even then, a new employee will not be at full production capacity for a number of weeks or months, depending on the skill involved. AIDS increases costs to the corporation and wages war on the very source of productivity, thereby reducing profits.
AIDS Results in Declining Profits for the Corporation
Beyond the increased costs and decreased productivity that result from the epidemic's direct attack upon members of the workforce worldwide, MNCs also experience a decline in profit as AIDS affects the customers of any given business. 81 Current trends support the conclusion that AIDS affects the supply end of business more dramatically than the demand end; however, 30 percent of the firms studied by the South African Business Coalition on HIV/AIDS believe that over the next five years, the AIDS crisis will negatively affect sales.
82
Shrinking regional markets are further affected as ill breadwinners are no longer able to work and thus lose the ability both to earn income and support their families. 83 The tremendous financial burdens on remaining family mem- bers to provide care and support to the sick and to provide proper funerals and burials intensify already fragile familial and communal structures. 84 The death of a family's wage earner often leads young people to enter the workforce prematurely in order to support their remaining family. 85 Especially negative longterm effects ensue when the death of a family's provider forces a child to leave school and begin to work. 86 The AIDS crisis continues to aggravate the macroeconomic consequences in many of the poverty-stricken regions in which MNCs operate, 87 where the epidemic is linked to reduced gross domestic product (GDP). 88 The GDP in subSaharan Africa is believed to have already decreased by 2 to 4 percent as a result of both the direct and indirect costs of AIDS. 89 Additionally, there may be decreased interest in financial investment throughout the country or region as investors remain cautious in light of economic and health instability.
No MNC is immune from the effects of the AIDS epidemic. 90 Even taking account of the many variables that may shape the severity with which the AIDS epidemic affects the profits, costs, and productivity of any given business, "[i]t is inevitable that a firm doing business in the developing world will pay for AIDS. It is just a question of when and how much." 91 In addition to increased awareness of the economic impact of the AIDS epidemic on the global workforce and the business operations of MNCs, good business sense dictates that prevention and 84. Id. 85. Id. 86. Id. at 11, 31-32. 87. 2004 Report, supra note 53, at 8-9. 88. HIV/AIDS and Work, supra note 45, at 5, 12-15. While the economic consequences in countries with a high occurrence rate of infection can be astronomical, it is difficult to measure the economic impact of AIDS in countries that are heavily populated but whose infection rate is low relative to the population. This difficulty applies to countries including India, China, Brazil, and the United States, even though each of these countries has more than a million HIV-infected citizens. Id. at 5.
89. Action Against AIDS: The Africa Region, supra note 65. 90. But see HIV/AIDS and Work, supra note 45, at 12 (suggesting that the size of the business as well as the level of expertise and skill required of the business' employees are factors that may exacerbate the felt effects).
91. HIV/AIDS in the Workplace, supra note 73, at 1 (quoting Lee Smith, Former President, Levi Strauss International). treatment plans be considered without delay before AIDS takes a further toll on the workforces of MNCs.
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C. Intervention Is Cost-Effective
The global AIDS epidemic is a business issue deserving the attention of MNCs; studies suggest that intervention outweighs cost. The Center for International Health at Boston University, for example, focused on southern Africa's formal business sector and developed a "costing model that estimates the present value of new HIV infections." 93 The research indicates that:
new infections can cost between 3.4 percent and 10.7 percent of annual salaries depending on skill level, associated benefits, and prevalence in the area. While treatment costs will vary considerably among companies depending on what segment of the workforce is targeted and the type of care offered . . . even for low-cost companies, the benefits associated with interventions appeared to outweigh the costs.
94
Other studies suggest similar conclusions. Findings have shown that turnover rates, as well as labor costs, are reduced through corporate efforts aimed both at prevention and provision of medical care for opportunistic and sexually transmitted infections. 95 A survey conducted in Kenya exemplifies the economic reality of the issue. While costs relating to HIV/AIDS may reach as much as an average of U.S.$56 annually per employee by 2005 if the infection rate continues to expand at its current pace, for as little as U.S.$15 per employee for the first year of implementation, an inclusive prevention plan can be provided.
96 . A former taskforce co-chair for the Corporate Council of Africa, Joe Sills, suggests that:
[a] corporation is going to come out far better by dealing initially with AIDS in its work force and trying to provide information to its families, than simply saying, "This is going to cost a lot of money up front." In training middle management, if these people drop like flies from AIDS, it will cost them a fortune. search drawn from specific regions indicates a cost-benefit analysis favoring early intervention. It is much harder to draw general conclusions concerning cost-effectiveness, given the great range of variables:
For example, a business operating in an existing high prevalence region or locality where the epidemic is well-advanced may have a very different cost-benefit scenario than a business located in an area where HIV incidence is relatively low but increasing. The former may see care and treatment programs for its workforce as a priority whereas, for the latter, an education and prevention campaign would bring cost-effective benefits. Other variables affecting cost may include: size of company, setting, industry sector, cost margin, ratio of skilled to unskilled workers, risk factors, HIV prevalence in the workforce, availability of government or NGO supported programs and facilities, etc.
97
The importance of assessing the impact of AIDS on the business operations of MNCs cannot be overemphasized. Because of the great number of variables involved, successful policy and program implementation depends on first recognizing and understanding the current impact of the epidemic on a specific workplace. A business may evaluate its individual situation by using tools such as the AIDS Impact Model for Business (AIM-B) designed by The Futures Group. 98 The instrument, which assists in evaluating the situation based on the cost and effects of AIDS, was commissioned by the Global Business Council on AIDS and is available for use at no initial cost. 99 Following assessment, MNCs will have a clearer picture of how operations are directly and indirectly affected by the epidemic and can target policies and programs to meet the AIDS-related needs of both the business as well as the employees. 97 . HIV/AIDS in the Workplace, supra note 73, at 2. But see id. at 4 (suggesting that "the approximate rate of infection of the workforce . . . in most cases, can be assumed to be similar to the rate for the local population.").
98 
Prevention
The critical fact at this time is that a majority of the global workforce is HIV-negative. 100 If MNCs act now, the growing global workforce crisis may be restrained. Corporations are naturally well suited to aid in prevention efforts, as they often have methods of delivery already in place and can provide information regarding the virus and effective methods of protection and prevention. 101 Coca-Cola, for example, has utilized its product delivery system to provide educational and prevention materials to various regions in Africa. 102 Shell Thailand participated in the program "Peer Education at the Pump," utilizing its service stations as information hubs. 103 Prevention offers widespread benefits as a result of increased interconnectedness, both regionally and globally. 104 Research shows, however, that while prevention is a necessary and effective method of curbing the AIDS crisis, fewer than one in five persons globally currently has access to "HIV prevention services."
105
In addition to providing preventative information and materials, MNCs may further reduce the rate of HIV/AIDS infection by addressing risky behaviors perpetuated by workplace conditions. For example, MNCs employing mobile and migratory workforces have acknowledged and begun to rectify the living situa-tions contributing to extremely high rates of infection among mining and other industry workers. 106 Prevention programs that take into account regional and workplace conditions, as well as cultural specificities, are best suited to reduce HIV/AIDS infection and transmission rates. 
Treatment
While prevention programs are a crucial step toward slowing and reversing the global workforce crisis, such programs fail to speak to workers already infected and the resulting decrease in productivity. Although a host of variables must again be considered in determining the true cost-effectiveness of treatment programs, reports have found that "many firms have concluded that the direct and indirect costs of inaction are far greater than the costs of treatment[,]" 108 and that "treatment programmes in the workplace . . . are increasingly seen by a range of enterprises as the least costly option to maintain profitability and ensure growth."
109 Presently, no known cure for HIV/AIDS exists, but antiretroviral drug treatment may substantially slow the physical devastation caused by the virus and even reverse the effects in advanced cases. 110 Treatment is a complicated proposition. It holds great promise, but concerns have been raised regarding severe side-effects. 111 A second fear is the danger of creating resistant strands of the virus if the necessary infrastructure needed to monitor effective use is not available or if patients do not fully adhere to treatment plans. 112 Beyond the difficulty of administration, the cost of treatment Treatment programs properly implemented can have a positive impact on the global workforce crisis:
[m]any people once relegated to the economic sidelines because of disease are now able to work, earn a living, and acquire the necessities of life that permit an ever-improving standard of living. . . . This increase in productivity raises the level of economic activity, enabling more and more businesses to invest in their employees' health.
Healthy workers are a key part of the cycle that increases productivity and leads to greater investment that results in medical innovations and improved human health.
123
Clearly, a delicate and careful combination of prevention and treatment is necessary to permanently curb the impact of AIDS on the global workforce.
124
Framing AIDS as a global workforce crisis illustrates how cost-effective intervention can be. 124. 2004 Report, supra note 53, at 11 ("Although antiretroviral treatment is bringing hope to millions, without sharply reducing the number of new HIV infections, expanded access to treatment becomes unsustainable. Providers of antiretroviral treatment will be swamped by demand."); see also Business and HIV/AIDS, supra note 47, at II (Peter Piot, Executive Director of UNAIDS, advises that the HIV-infection rate of the countries in which a company does business should help to guide decisions regarding whether to focus predominantly on workplace policies and prevention or treatment alongside of prevention programs.). Although workplace prevention and treatment programs combine to curb the direct negative impact of the AIDS epidemic with regard to increased costs as well as reduced productivity and profits, some corporations choose to side-step the issue completely by indirect, and ultimately ineffective, means. The ILO notes that "[s]ome companies have outsourced production activities, shifted from labour-intensive to capitalintensive technologies, or attempted to avoid hiring new employees who may be HIV-positive (or who belong to seemingly high-risk groups)." HIV/AIDS and Work, supra note 45, at 19. Furthermore, "anecdotal evidence from diverse sources [suggests] that pre-employment testing is taking place in high-prevalence countries, even where this is against the law or national policy." Id. These actions, however, do not provide a sustainable solution and, therefore, should not be viewed as legitimate responses.
D. Limitations and Criticisms Under a Corporate Responsibility Framework Dispelled Under the Global Workforce Crisis Framework
This Part concludes with the suggestion that the proposed framework of AIDS as a global workforce crisis may dispel limitations and criticisms inherent under the current framework of corporate social responsibility-the voluntary nature and lack of enforcement, the "bottom line" as the only concern of MNCs, and the insufficiency and nonsustainability of the current response.
Lack of Enforcement and Voluntary Nature
While the proposed framework does not alter the underlying voluntary nature of action, it does reinforce existing, and provide additional, internal motivation for MNCs to act. As MNCs take ownership of the crisis and realize that responsiveness also serves their "self-interest, to protect [their] investment," 125 the incredible need for methods of enforcement dissipates. Enforcement mechanisms, in fact, are only necessary in circumstances where internal motivations do not suffice as a driving force for action.
Enforcement between MNCs will also develop to prevent the possibility of regional "free-riders." Corporations concerned with curbing the threat to the global workforce will force fellow corporations to internalize AIDS-related costs, for "[w]here a company is making efforts to reduce the rate of infection within its own workforce, it is in that company's best interests that its neighbors-even its competitors-do likewise." 126 The resulting regional and global business coalitions serve as tools of accountability. 127 Individual nations have also established business coalitions against AIDS. 128 MNCs will also answer to partnerships with NGOs and other non-MNC entities such as the joint ventures between DaimlerChrysler South Africa and the German Technical Cooperation Agency; 129 Unilever and the Ghana Social Marketing Foundation; 130 and Heineken with PharmAccess International and the German Development Co-operation. 131 Another example of a unique partnership forged as a result of the emerging AIDS epidemic is between the insurance firm American International Assurance Thailand and businesses operating in Thailand. As an incentive to promote HIV/AIDS action on the part of employers, the insurance company offers group life insurance premium discounts of 5 to 10 percent to companies engaged in effective nondiscriminatory and preventative HIV/ AIDS practices in the workplace. 132 Finally, the concern that MNCs will "fold up" business and move elsewhere in the face of too much external pressure cannot hold true. Not only are there vast expenses in reestablishing operations and bringing a new workforce up to speed, but statistics substantiate the reality that MNCs will face the global AIDS crisis wherever they operate. 133 
The "Bottom Line" As Multinational Corporations' Only Concern
Is viewing the AIDS crisis in terms of economic implications truly as harmful as some critics believe? 134 If, "[a]t the micro level, businesses will feel the impact of HIV/ AIDS most clearly through their workforce, with direct consequences for a company's bottom line," 135 then this recognition will encourage, rather than discourage, MNCs to act. Even Kofi Annan, United Nations Secretary-General, recognized the importance of using the language of corporate costs and profits to induce action:
It is high time we tapped the strengths of the business sector to the full. AIDS affects business. The spread of the pandemic has caused business costs to expand, and markets to shrink. As both the current balance sheet and future indicators show, the business community needs to get involved to protect its bottom line. . . . There are already several examples that prove the unparalleled positive impact that corporate action can have in the fight against HIV/AIDS. It is time to turn those examples into concerted and strategic action in the workplace, in advocacy and in building on . . . corporate strengths. 136 If the criticism that MNCs possess too much power and influence globally is indeed true, then corporations can use it to push for further reductions in antiretroviral drug prices. Although prices of antiretroviral drugs appear to be dropping due to current pressure on the pharmaceutical industry, 137 the price remains extremely high in some regions. 138 MNCs can join forces and negotiate with drug companies to reduce rates for bulk purchases.
139 They can also use their enormous lobbying power for research and development of other, easier to administer, treatment options such as an AIDS vaccination 140 and microbicides. [W]hat the banners of protestors outside the drug companies ought to be saying is not "Free Drugs" but "Where Are Your Vaccines?". Most vaccines require one or two injections, in contrast to a lifetime's dependence on drugs that are proving highly lucrative, for the pharmaceutical industry. The number of scientists working on HIV vaccines throughout the world is about 100. Almost none of them work for commercial drug companies. 
Id. See also
Insufficiency/Nonsustainability of the Current Response of MNCs
The final criticism under the framework of corporate social responsibility will be dispelled as prevention and treatment prove cost-effective to MNCs. Short-term and inconsistent action does not equate with cost-effectiveness, and, therefore, the economic reality of the situation will require MNCs to commit enough time and resources to provide responses that are significant, lasting, and effective against the global workforce crisis.
Conclusion
As "no single approach to resource mobilization is likely to overcome HIV/ AIDS," 142 this Note develops an additional language by which both MNCs and their critics may engage in meaningful and persuasive dialogue regarding the appropriate and necessary responses to the global AIDS crisis. The impact of the AIDS epidemic on the global workforce as well as on the costs, productivity, and profits of MNCs provides renewed internal motivation not present under the corporate social responsibility framework. Critics who present strong evidence of the impact of the AIDS epidemic on the global workforce and the cost-effectiveness of intervention provide an internal, economically-focused motivation to act. Focusing on the workforce crisis model to the exclusion of human rights and corporate responsibility may, however, be a risky proposition. Cost-effectiveness arguments will not necessarily carry the same weight in every situation. On these occasions, action must still be urged on the basis of corporate social responsibility.
MNCs hold a unique position of effectiveness against this global devastation. 143 Greater incentive, creativity, action, and commitment on the part of MNCs transpire when critics frame the issue in terms that make good business and economic sense. Perhaps the talk will no longer end in the newspaper, 144 the law journal article, or the corporate code of conduct. Through meaningful and persuasive dialogue, "the talk" will end in deliberate, decisive, and significant action by MNCs.
142. Currie, supra note 64, at 128. 143. Schwab, supra note 47, at I. ("[T]he role of business will continue to evolve as businesses explore how to best contribute their strengths and capabilities to address areas of greatest need.").
144. Fugard et al., supra note 1, at 4.
